DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 205641
Email this page to a colleague
» See Plans and Pricing
NDA 205641 describes ASMANEX HFA, which is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. Additional details are available on the ASMANEX HFA profile page.
The generic ingredient in ASMANEX HFA is mometasone furoate. There are thirty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
The generic ingredient in ASMANEX HFA is mometasone furoate. There are thirty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 205641
| Tradename: | ASMANEX HFA |
| Applicant: | Merck Sharp Dohme |
| Ingredient: | mometasone furoate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 205641
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 205641
Suppliers and Packaging for NDA: 205641
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641 | NDA | Merck Sharp & Dohme Corp. | 0085-2222 | 0085-2222-01 | 1 CANISTER in 1 CARTON (0085-2222-01) > 120 AEROSOL in 1 CANISTER |
| ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641 | NDA | Merck Sharp & Dohme Corp. | 0085-2222 | 0085-2222-02 | 1 CANISTER in 1 CARTON (0085-2222-02) > 120 AEROSOL in 1 CANISTER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.10MG/INH | ||||
| Approval Date: | Apr 25, 2014 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.20MG/INH | ||||
| Approval Date: | Apr 25, 2014 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.05MG/INH | ||||
| Approval Date: | Aug 12, 2019 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 205641
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641-002 | Apr 25, 2014 | Start Trial | Start Trial |
| Merck Sharp Dohme | ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641-002 | Apr 25, 2014 | Start Trial | Start Trial |
| Merck Sharp Dohme | ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641-001 | Apr 25, 2014 | Start Trial | Start Trial |
| Merck Sharp Dohme | ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641-002 | Apr 25, 2014 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
